NCT04978012 2022-06-07Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line ChemotherapyFudan UniversityPhase 2 Unknown48 enrolled
NCT04453826 2020-09-28Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 3 Recruiting388 enrolled